PERTH: Bigtincan Holdings Limited has announced that the acquisition of Agnitio A/S has completed.
Founded in 2001, Agnitio is a pioneer in sales enablement for the life sciences sector and played an integral part in creating the market for innovative customer engagement technologies.
Agnitio solutions enable pharma and medtech companies to respond to the needs of their customers in the age of COVID19, enabling and supporting health care professionals, payers, and other healthcare stakeholders.
Bigtincan (ASX:BTH) helps sales and service teams increase win rates and customer satisfaction. The company’s mobile, AI-powered sales enablement automation platform features the industry’s premier user experience that empowers reps to more effectively engage with customers and prospects and encourages team-wide adoption. Leading brands including AT&T, Thermo Fisher, Merck, ANZ Bank and others rely on Bigtincan to enhance sales productivity and fuel customer engagement.
With global sales and marketing headquartered in Boston, Bigtincan also has offices across EMEA, Australia and Asia.